Product Reports Resources Pricing Login Book a demo

CathVision

Health Tech & Medtech · Copenhagen, Denmark · Founded 2010

Ablation therapy of cardiac arrhythmia with novel hardware, software and data science MoreLess

CathVision is a pioneering startup focused on advancing the field of cardiac electrophysiology, specifically targeting the treatment of cardiac arrhythmias. The company is dedicated to empowering electrophysiologists—specialists who study and treat the electrical activities of the heart—to more effectively diagnose and cure arrhythmias. Cardiac arrhythmias, such as atrial fibrillation, affect approximately 20 million people globally and are associated with severe health issues like strokes and heart failure.

CathVision operates in the medical technology market, particularly within the niche of interventional electrophysiology. The company's flagship product, the CathVision Cube, is designed to record high-quality intracardiac electrograms. These are electrical signals from within the heart that help doctors distinguish between true clinical signals and artifacts (false signals). This differentiation is crucial for the success of procedures like ablation, a treatment that aims to cure arrhythmias by destroying the tissue causing the irregular heartbeat.

The business model of CathVision revolves around developing and providing cutting-edge medical devices to hospitals and clinics. Currently, their product is in the investigational stage, meaning it is being tested and is not yet available for commercial sale. The company is actively seeking partnerships with hospitals for a limited market release to further evaluate their product's effectiveness.

CathVision generates revenue through funding and grants, notably from the European Union's Horizon 2020 research and innovation program. This funding supports the development and testing of their medical devices. Once the product is commercially available, the company will likely generate income through direct sales to hospitals and clinics, as well as potential licensing agreements.

In summary, CathVision is a medical technology startup focused on improving the diagnosis and treatment of cardiac arrhythmias through advanced electrophysiology tools. Their innovative approach aims to enhance the precision and effectiveness of heart treatments, ultimately benefiting millions of patients worldwide.

Keywords: Cardiac, Electrophysiology, Arrhythmia, Medical Device, Innovation, Hospitals, Ablation, Intracardiac Electrograms, Horizon 2020, Healthcare.

Company overview

CathVision company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
2010
Headquarters
Copenhagen, Denmark
Employees
40
Open positions
1
Dealroom signal
74.1
client focusb2btechnologyArtificial IntelligencetechnologyHardwaretechnologyDeep TechtechnologyMachine Learningsub industryMedical Devicesbusiness modelManufacturingindustryHealthsectorCardiology and cardiovascularsectorMedical ImagingsectorCore AIsectorTech for Hospitals and ClinicssectorClinical Decision SupportsectorTech for Medical Professionals

Valuation & funding

CathVision funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SUPPORT PROGRAMOther financing Oct 2025 $0 HealthTech Arkansas · MedAxiom · HeartX
LATE VCEquity / VC Jul 2023 $9M $71M Undisclosed
LATE VCEquity / VC Aug 2022 $7.2M $71M Undisclosed
SECONDARYOther financing Jan 2021 $0 Nordic Secondary Fund
LATE VCEquity / VC May 2020 $14M $57M Undisclosed
GRANTOther financing Oct 2019 European Commission
EARLY VCEquity / VC Jul 2017 Borean Innovation
SEEDEquity / VC Dec 2015 Innovation Fund Denmark · Borean Innovation
SEEDEquity / VC Apr 2014 Market Maturation Fund · Borean Innovation
Showing 9 recorded eventsUnlock the complete deal history →

Financials

Revenue, earnings and profit over time

Reported history and available estimates. Estimated years are marked “E”; sparse fields are left blank rather than inferred.

YearEBITDAMarginProfitMarginR&D
2026 −$3.2M −$5.7M $0
2025 −$3.2M −$5.7M $0
2024 −$3.2M −$5.7M $0
2023 −$3.2M $0
2022 −$3.2M
2021 −$1.3M
2020 −$1M
Company filings, research estimates and Dealroom dataOpen the full financial model →

Growth signals

CathVision website traffic

Latest recorded traffic for CathVision is 1.8K monthly website visits, up 100% over the last three months. CathVision's team grew 0% over the past year.

Latest monthly visits1.8K 3-month web change+100% 1-year team growth0%
Monthly website visits96 observations · Nov 2016–Jul 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Hiring

Open positions at CathVision

Current openings linked to this company in Dealroom.

1 distinct opening shownExplore hiring signals →

Comparisons

CathVision compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

CathVision's talent

Book a demo to see the people
Team profiled 10 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

9 investors on CathVision's cap table

Sourced from Dealroom's funding and investor records.

Seed 4 investors entered at this stage
Market Maturation Fund
Borean Innovation
Innovation Fund Denmark
European Commission
Series B+ 1 investor entered at this stage
Nordic Secondary Fund
Other known 4 additional known investors
HealthTech Arkansas
HeartX
MedAxiom
Export and Investment Fund of Denmark

Global footprint

Where CathVision has talent and traffic

Workforce by country
8 countries with
team presence
🇩🇰 Denmark59.4%
🇺🇸 United States15.6%
🇨🇭 Switzerland6.3%
🇵🇱 Poland6.3%
🇧🇪 Belgium3.1%
Top 5 of 8 shown

In the news

Latest news about CathVision

Recent press, funding announcements, and product moves mentioning CathVision — open to read from the original sources.

See all news

Market sentiment

What the market is saying about CathVision

An AI-synthesized read of the highest-engagement posts about CathVision on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See CathVision’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.